NovaBridge Biosciences (NBP) Change in Cash (2019 - 2025)
NovaBridge Biosciences (NBP) reported Change in Cash of -$17.4 million for Q4 2025, down 57.56% year-over-year from -$41.1 million in Q4 2024, and down 127.82% on a QoQ basis from $62.7 million in Q3 2025.
NovaBridge Biosciences (NBP) has 4 years of Change in Cash data on file, last reported at -$17.4 million in Q4 2025.
- Quarterly Change in Cash fell 57.56% year-over-year to -$17.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$38.5 million (down 109.86% YoY) and the FY2025 annual result came in at $142.4 million, up 158.73% from the prior year.
- Change in Cash eased to -$17.4 million in Q4 2025 per NBP's latest filing, from $62.7 million in the prior quarter.
- Across five years, Change in Cash topped out at $62.7 million in Q3 2025 and bottomed at -$72.6 million in Q3 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.43 Mn |
| Sep 30, 2025 | 62.66 Mn |
| Dec 31, 2024 | -11.06 Mn |
| Sep 30, 2024 | -72.63 Mn |
| Dec 31, 2020 | 271.42 Mn |
| Sep 30, 2020 | 202.27 Mn |
| Dec 31, 2019 | -12.45 Mn |